Although it has been reported rarely in the literature in patients who develop acute kidney injury after COVID-19 disease, ANCA-related vasculitis should also be kept in mind. Thus, it is possible to reduce mortality and morbidity. We presented a middle-aged male patient who was diagnosed with post-COVID ANCA-associated vasculitis.
Ersoy A. COVID-19 and kidney diseases. In: Ursavaş A, Akalın H, eds. COVID-19. 1. ed. Bursa: Medyay Kitabevi; 2021:429-40.
Wong K, Farooq Alam Shah MU, Khurshid M, Ullah I, Tahir MJ, Yousaf Z. COVID-19 associated vasculitis: A systematic review of case reports and case series. Ann Med Surg (Lond). 2022 Feb;74:103249. doi: 10.1016/j.amsu.2022.103249.
Prendecki M, Clarke C, Cairns T, Cook T, Roufosse C, Thomas D, Willicombe M, Pusey CD, McAdoo SP. Anti-glomerular basement membrane disease during the COVID-19 pandemic. Kidney Int. 2020 Sep;98(3):780-1. doi: 10.1016/j.kint.2020.06.009.
Suso AS, Mon C, Oñate Alonso I, Galindo Romo K, Juarez RC, Ramírez CL, Sánchez Sánchez M, Mercado Valdivia V, Ortiz Librero M, Oliet Pala A, Ortega Marcos O, Herrero Berron JC, Silvestre Torner N, Alonso Riaño M, Pascual Martin A. IgA vasculitis with nephritis(Henoch-Schönlein purpura) in a COVID-19 patient. Kidney Int Rep. 2020 Nov;5(11):2074-8. doi:10.1016/j.ekir.2020.08.016.
Uppal NN, Kello N, Shah HH, Khanin Y, De Oleo IR, Epstein E, Sharma P, Larsen CP, Bijol V, Jhaveri KD. De novo ANCA- associated vasculitis with glomerulonephritis in COVID-19. Kidney Int Rep. 2020 Nov;5(11):2079-83. doi: 10.1016/j.ekir.2020.08.012.
Morris D, Patel K, Rahimi O, Sanyurah O, Iardino A, Khan 9. N. ANCA vasculitis: A manifestation of Post-Covid-19 Syndrome. Respir Med Case Rep. 2021;34:101549. doi: 10.1016/j. rmcr.2021.101549.
Moeinzadeh F, Dezfouli M, Naimi A, Shahidi S, Moradi H. Newly diagnosed glomerulonephritis during COVID-19 infection undergoing immunosuppression therapy, a case report. Iran J Kidney Dis. 2020 May;14(3):239-42.
Jalalzadeh M, Valencia-Manrique JC, Boma N, Chaudhari A, Chaudhari S. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in a case of scleroderma after recent diagnosis with COVID-19. Cureus. 2021 Jan 4;13(1):e12485. doi: 10.7759/ cureus.12485.
Izci Duran T, Turkmen E, Dilek M, Sayarlioglu H, Arik N. ANCA-associated vasculitis after COVID-19. Rheumatol Int. 2021 Aug;41(8):1523-9. doi: 10.1007/s00296-021-04914-3.
Ersoy A. COVID-19 and kidney diseases. In: Ursavaş A, Akalın H, eds. COVID-19. 1. ed. Bursa: Medyay Kitabevi; 2021:429-40.
Wong K, Farooq Alam Shah MU, Khurshid M, Ullah I, Tahir MJ, Yousaf Z. COVID-19 associated vasculitis: A systematic review of case reports and case series. Ann Med Surg (Lond). 2022 Feb;74:103249. doi: 10.1016/j.amsu.2022.103249.
Prendecki M, Clarke C, Cairns T, Cook T, Roufosse C, Thomas D, Willicombe M, Pusey CD, McAdoo SP. Anti-glomerular basement membrane disease during the COVID-19 pandemic. Kidney Int. 2020 Sep;98(3):780-1. doi: 10.1016/j.kint.2020.06.009.
Suso AS, Mon C, Oñate Alonso I, Galindo Romo K, Juarez RC, Ramírez CL, Sánchez Sánchez M, Mercado Valdivia V, Ortiz Librero M, Oliet Pala A, Ortega Marcos O, Herrero Berron JC, Silvestre Torner N, Alonso Riaño M, Pascual Martin A. IgA vasculitis with nephritis(Henoch-Schönlein purpura) in a COVID-19 patient. Kidney Int Rep. 2020 Nov;5(11):2074-8. doi:10.1016/j.ekir.2020.08.016.
Uppal NN, Kello N, Shah HH, Khanin Y, De Oleo IR, Epstein E, Sharma P, Larsen CP, Bijol V, Jhaveri KD. De novo ANCA- associated vasculitis with glomerulonephritis in COVID-19. Kidney Int Rep. 2020 Nov;5(11):2079-83. doi: 10.1016/j.ekir.2020.08.012.
Morris D, Patel K, Rahimi O, Sanyurah O, Iardino A, Khan 9. N. ANCA vasculitis: A manifestation of Post-Covid-19 Syndrome. Respir Med Case Rep. 2021;34:101549. doi: 10.1016/j. rmcr.2021.101549.
Moeinzadeh F, Dezfouli M, Naimi A, Shahidi S, Moradi H. Newly diagnosed glomerulonephritis during COVID-19 infection undergoing immunosuppression therapy, a case report. Iran J Kidney Dis. 2020 May;14(3):239-42.
Jalalzadeh M, Valencia-Manrique JC, Boma N, Chaudhari A, Chaudhari S. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in a case of scleroderma after recent diagnosis with COVID-19. Cureus. 2021 Jan 4;13(1):e12485. doi: 10.7759/ cureus.12485.
Izci Duran T, Turkmen E, Dilek M, Sayarlioglu H, Arik N. ANCA-associated vasculitis after COVID-19. Rheumatol Int. 2021 Aug;41(8):1523-9. doi: 10.1007/s00296-021-04914-3.
Mehmet Sezen
ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE)0000-0001-5796-6445Türkiye
Abdülmecit Yıldız
ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE)0000-0001-5941-9103Türkiye
Kamil Dilek
ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE)0000-0001-6149-1913Türkiye
Mustafa Güllülü
ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE)0000-0002-8911-7189Türkiye
Mahmut Yavuz
ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE)0000-0001-6755-6386Türkiye
Ayşegül Oruç
ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE)0000-0002-0342-9692Türkiye
Saide Güllülü
ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE)0000-0001-6048-1879Türkiye
Alparslan Ersoy
ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE)0000-0002-0710-0923Türkiye
Özerik K, Sezen M, Yıldız A, Dilek K, Güllülü M, Yavuz M, Oruç A, Güllülü S, Ersoy A (April 1, 2022) Post-COVID ANCA-Associated Vasculitis: A Case Report. Turkish Journal of Internal Medicine 4 182–185.
Turkish Journal of Internal Medicine, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.